Related Experiment Video

Updated: Jun 13, 2025

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

2.5K

The Ubiquitin-Conjugating Enzyme E2 O (UBE2O) and Its Therapeutic Potential in Human Leukemias and Solid Tumors

Beatrice Maffeo1, Daniela Cilloni1

  • 1Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.

Cancers
|September 14, 2024
PubMed

Insights

The ubiquitin-conjugating enzyme E2 O (UBE2O) is crucial for cellular homeostasis. This review explores UBE2O

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cellular homeostasis relies on precise protein degradation.
  • The ubiquitination system targets proteins for proteasome degradation.
  • Ubiquitin-conjugating enzyme E2 O (UBE2O) plays a key role in these processes.

Purpose of the Study:

  • To review the biological and physiological roles of UBE2O.
  • To discuss the implications of UBE2O in human diseases, especially cancers.
  • To highlight UBE2O as a potential therapeutic target for cancer treatment.

Main Methods:

  • Literature review of scientific articles on UBE2O.
  • Analysis of UBE2O's function in cellular processes.
  • Examination of UBE2O's involvement in disease pathogenesis.

Main Results:

  • UBE2O is implicated in diverse biological functions.
  • Dysregulation of UBE2O is associated with leukemias and solid cancers.
  • UBE2O's role in cancer suggests its potential as a therapeutic target.

Conclusions:

  • UBE2O is a significant factor in cellular homeostasis and disease.
  • Targeting UBE2O may offer novel therapeutic strategies for cancer.
  • Further research into UBE2O could unlock new cancer treatment perspectives.
Keywords:
UBE2OUPSerythropoiesisleukemiaprotein degradationsolid tumorsubiquitin

More Related Videos

In Vitro Analysis of E3 Ubiquitin Ligase Function06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

5.1K
Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

8.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.2K